Skip to main content

Advertisement

Table 1 Patient and tumor characteristic (n = 252)

From: Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer

Characteristics N° Patients (%)
Stage  
   ≤ T2a 36 (14%)
   T2b 58 (23%)
   ≥ T2c 158 (63%)
Geason score:  
   ≤ 6 109 (43%)
   = 7 77 (31%)
   > 7 66 (26%)
Pretreatment PSA (ng/ml)  
   ≤ 10 44 (17%)
   10.1-20 101 (40%)
   > 20 107 (43%)
   Mean:20/Median 18 (2.05-59.60)  
Adjuvant hormonal ablation  
   Yes 173 (69%)
   No 79 (31%)
Age at diagnosis (yr)  
   ≤ 60 32 (13%)
   61-70 131 (52%)
   > 70 89 (35%)
Risk Level  
   High Risk by Gleason y/o PSA 187 (74%)
   High Risk by T 65 (26%)
No. Prognostic factors  
   2 intermediate Risk Criteria 44 (17%)
   1 High Risk Criteria 100 (40%)
   2 High Risk Criteria 89 (35%)
   > 2 Risk Criteria 19 (8%)
Gland Vol. Implant (cc): Mean:34/Median 31 (9-87)